Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Net loss	$ (3,986)	$ (4,365)
Available for sale securities - net unrealized (loss) income	(2)	14
Total other comprehensive (loss) income	(2)	14
Comprehensive loss	(3,988)	(4,351)
Comprehensive income attributable to noncontrolling interests	4	2
Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders	$ (3,992)	$ (4,353)